Group 1 - The core point of the article is that Da An Gene has received a medical device registration certificate from the National Medical Products Administration for its "Human MTHFR Gene Typing Detection Kit" [2] - In the fiscal year 2024, Da An Gene's revenue composition is projected to be 96.2% from the biopharmaceutical sector and 3.8% from financial services [2]